Dalma is an animal insurance company focused on providing pet owners with transparent, subscription-based health insurance. The company’s platform is designed to be user-friendly, offering coverage that reimburses costs associated with illnesses, injuries, and preventive care for pets. In addition to financial support, Dalma also provides customers with free unlimited access to veterinary advice and tips, facilitating better care for their animals. Through its digital approach, Dalma aims to simplify the insurance process for pet owners and enhance their overall experience in managing their pets' health.
Dalma is an animal insurance company focused on providing pet owners with transparent, subscription-based health insurance. The company’s platform is designed to be user-friendly, offering coverage that reimburses costs associated with illnesses, injuries, and preventive care for pets. In addition to financial support, Dalma also provides customers with free unlimited access to veterinary advice and tips, facilitating better care for their animals. Through its digital approach, Dalma aims to simplify the insurance process for pet owners and enhance their overall experience in managing their pets' health.
Animol Discovery
Series C in 2024
Animol Discovery is a biotechnology company focused on developing proprietary veterinary small molecules to address the medical needs of animals. Led by a team of experts with extensive experience in the animal health industry, Animol utilizes a unique technology platform that leverages DNA-encoded chemicals. This innovative approach allows for accelerated ultra-high throughput screening, enabling the simultaneous evaluation of target and anti-target activities. By streamlining the drug discovery process, Animol aims to deliver effective and innovative medicines tailored specifically for veterinary patients, ultimately improving treatment options available to pet owners.
Animol Discovery
Series B in 2023
Animol Discovery is a biotechnology company focused on developing proprietary veterinary small molecules to address the medical needs of animals. Led by a team of experts with extensive experience in the animal health industry, Animol utilizes a unique technology platform that leverages DNA-encoded chemicals. This innovative approach allows for accelerated ultra-high throughput screening, enabling the simultaneous evaluation of target and anti-target activities. By streamlining the drug discovery process, Animol aims to deliver effective and innovative medicines tailored specifically for veterinary patients, ultimately improving treatment options available to pet owners.
Dalma is an animal insurance company focused on providing pet owners with transparent, subscription-based health insurance. The company’s platform is designed to be user-friendly, offering coverage that reimburses costs associated with illnesses, injuries, and preventive care for pets. In addition to financial support, Dalma also provides customers with free unlimited access to veterinary advice and tips, facilitating better care for their animals. Through its digital approach, Dalma aims to simplify the insurance process for pet owners and enhance their overall experience in managing their pets' health.
Animol Discovery
Series B in 2022
Animol Discovery is a biotechnology company focused on developing proprietary veterinary small molecules to address the medical needs of animals. Led by a team of experts with extensive experience in the animal health industry, Animol utilizes a unique technology platform that leverages DNA-encoded chemicals. This innovative approach allows for accelerated ultra-high throughput screening, enabling the simultaneous evaluation of target and anti-target activities. By streamlining the drug discovery process, Animol aims to deliver effective and innovative medicines tailored specifically for veterinary patients, ultimately improving treatment options available to pet owners.
Dalma is an animal insurance company focused on providing pet owners with transparent, subscription-based health insurance. The company’s platform is designed to be user-friendly, offering coverage that reimburses costs associated with illnesses, injuries, and preventive care for pets. In addition to financial support, Dalma also provides customers with free unlimited access to veterinary advice and tips, facilitating better care for their animals. Through its digital approach, Dalma aims to simplify the insurance process for pet owners and enhance their overall experience in managing their pets' health.
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of protein-based therapeutics for animal health care and veterinary medicine. The company employs a team of veterinary scientists and clinicians dedicated to the discovery and development of biotherapeutics for both pets and farm animals. Invetx aims to transform the animal health industry by leveraging biopharmaceutical technologies to improve health outcomes significantly. By combining deep expertise in veterinary science with innovative therapeutic solutions, Invetx seeks to advance the future of animal care, providing effective treatments that cater to the needs of various animal populations.
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of protein-based therapeutics for animal health care and veterinary medicine. The company employs a team of veterinary scientists and clinicians dedicated to the discovery and development of biotherapeutics for both pets and farm animals. Invetx aims to transform the animal health industry by leveraging biopharmaceutical technologies to improve health outcomes significantly. By combining deep expertise in veterinary science with innovative therapeutic solutions, Invetx seeks to advance the future of animal care, providing effective treatments that cater to the needs of various animal populations.
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of protein-based therapeutics for animal health care and veterinary medicine. The company employs a team of veterinary scientists and clinicians dedicated to the discovery and development of biotherapeutics for both pets and farm animals. Invetx aims to transform the animal health industry by leveraging biopharmaceutical technologies to improve health outcomes significantly. By combining deep expertise in veterinary science with innovative therapeutic solutions, Invetx seeks to advance the future of animal care, providing effective treatments that cater to the needs of various animal populations.
Animol Discovery
Series A in 2020
Animol Discovery is a biotechnology company focused on developing proprietary veterinary small molecules to address the medical needs of animals. Led by a team of experts with extensive experience in the animal health industry, Animol utilizes a unique technology platform that leverages DNA-encoded chemicals. This innovative approach allows for accelerated ultra-high throughput screening, enabling the simultaneous evaluation of target and anti-target activities. By streamlining the drug discovery process, Animol aims to deliver effective and innovative medicines tailored specifically for veterinary patients, ultimately improving treatment options available to pet owners.